| Solara Active Pharma Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 541540 |
NSE Symbol : SOLARA |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE624Z01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.01 |
|
Book Value(₹) : 345.21 |
Market Cap(₹Cr) : 2,430.40 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 313.54 | 319.15 | 273.01 | 300.31 | 346.95 | 363.49 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 313.54 | 319.15 | 273.01 | 300.31 | 346.95 | 363.49 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.49 | 0.98 | 5.95 | 1.49 | 0.32 | 1.38 |
| Total Income | 314.03 | 320.13 | 278.96 | 301.80 | 347.27 | 364.87 |
| Total Expenditure | 278.79 | 262.12 | 230.42 | 242.62 | 285.63 | 321.25 |
| PBIDT | 35.24 | 58.01 | 48.54 | 59.18 | 61.64 | 43.62 |
| Interest | 20.83 | 23.90 | 29.12 | 26.54 | 28.28 | 30.87 |
| PBDT | 14.41 | 34.11 | 19.42 | 32.64 | 33.36 | 12.75 |
| Depreciation | 24.49 | 23.58 | 24.30 | 24.54 | 25.34 | 25.07 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -10.08 | 10.53 | -4.88 | 8.10 | 8.02 | -12.32 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -10.08 | 10.53 | -4.88 | 8.10 | 8.02 | -12.32 |
| EPS (Unit Curr.) | -2.36 | 2.46 | -1.65 | 2.47 | 2.11 | -3.20 |
| EPS (Adj) (Unit Curr.) | -2.36 | 2.46 | -1.65 | 2.47 | 2.11 | -3.20 |
| Calculated EPS (Unit Curr.) | -2.27 | 2.37 | -1.21 | 2.01 | 1.99 | -3.06 |
| Calculated EPS (Adj) (Unit Curr.) | -2.27 | 2.37 | -1.21 | 2.01 | 1.99 | -3.06 |
| Calculated EPS (Ann.) (Unit Curr.) | -9.07 | 9.50 | -4.85 | 8.05 | 7.98 | -12.26 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -9.07 | 9.50 | -4.85 | 8.05 | 7.98 | -12.26 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 44.47 | 44.34 | 40.25 | 40.25 | 40.21 | 40.21 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 11.24 | 18.18 | 17.78 | 19.71 | 17.77 | 12.00 |
| PBDTM(%) | 4.60 | 10.69 | 7.11 | 10.87 | 9.62 | 3.51 |
| PATM(%) | -3.21 | 3.30 | -1.79 | 2.70 | 2.31 | -3.39 |